SOTERA HEALTH COMPANY Current Income Tax Expense (Benefit)
SOTERA HEALTH COMPANY (SHC) reported Current Income Tax Expense (Benefit) of $69.53 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-02-24
- SOTERA HEALTH COMPANY current income tax expense (benefit) for the quarter ending 2021-12-31 was $71.01M.
- SOTERA HEALTH COMPANY current income tax expense (benefit) for the quarter ending 2021-09-30 was $400.00K.
- SOTERA HEALTH COMPANY current income tax expense (benefit) for the quarter ending 2021-06-30 was $0.00.
- SOTERA HEALTH COMPANY current income tax expense (benefit) for the quarter ending 2021-03-31 was -$9.10M.
- SOTERA HEALTH COMPANY current income tax expense (benefit) for fiscal 2025 was $69.53M, a 15.81% increase from fiscal 2024.
- SOTERA HEALTH COMPANY current income tax expense (benefit) for fiscal 2024 was $60.04M, a 17.27% increase from fiscal 2023.
- SOTERA HEALTH COMPANY current income tax expense (benefit) for fiscal 2023 was $51.20M, a 20.52% decline from fiscal 2022.
- SOTERA HEALTH COMPANY current income tax expense (benefit) for fiscal 2022 was $64.42M, a 3.38% increase from fiscal 2021.
| Period end | Current Income Tax Expense (Benefit) 3 month | Current Income Tax Expense (Benefit) 6 month | Current Income Tax Expense (Benefit) 9 month | Current Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $69.53M 10-K · filed 2026-02-24 | |||
| 2024-12-31 | $60.04M 10-K · filed 2026-02-24 | |||
| 2023-12-31 | $51.20M 10-K · filed 2026-02-24 | |||
| 2022-12-31 | $64.42M 10-K · filed 2025-02-27 | |||
| 2021-12-31 | $71.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $71.41M derived: sum of 2 quarters · filed 2024-02-27 | $71.41M derived: sum of 3 quarters · filed 2024-02-27 | $62.31M 10-K · filed 2024-02-27 |
| 2021-09-30 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $400.00K derived: sum of 2 quarters · filed 2021-11-10 | -$8.70M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$9.10M 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | -$9.10M 10-Q · filed 2021-05-13 | |||
| 2020-12-31 | $21.99M 10-K · filed 2023-02-28 | |||
| 2019-12-31 | $38.50M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |